from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2446c/-

LFCtreatmentdescriptionclass of inhibitor

-0.720

Amikacinug/mL Amikacintranslation

-1.818

Cap5-10ug/mL Capreomycintranslation

-0.948

Rox10-50 ug/mL Roxithromycintranslation

-0.309

SM2-5 ug/mL Streptomycintranslation

-1.461

Tet5-10 ug/mL Tetracyclinetranslation

-0.081

Rif0.2-5ug/mL Rifampicintranscription

-1.904

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.450

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.403

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.370

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.370

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.733

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.204

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.851

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.220

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.964

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.152

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.351

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.930

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.065

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.006

KCN5-20 ug/mL Potassium cyaniderespiration

-0.035

NaN30.2-2 mM Sodium aziderespiration

0.146

Nigericin50 uM Nigericinrespiration

-0.808

TRC10-150 ug/mL Triclosanrespiration

-0.406

TRZ10-25 ug/mL Thioridazinerespiration

-0.864

Valinomycin0.5-10 uM Valinomycinrespiration

-0.711

ZnSO42 mM ZnSO4respiration

0.023

menadione6-10 ug/mL Menadionerespiration

-0.306

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.308

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.510

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.507

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.704

NRP_1Non-replicating persistence stage 1dosRassociated

0.376

Amp0.2mg/mL AmpicillincellWall

0.155

Cephalexin20-100 ug/mL CephalexincellWall

-0.292

Cerulenin0.32-5 ug/mL CerulenincellWall

0.596

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.615

EMB10-20 ug/mL EthambutolcellWall

-0.599

Eta12-40 ug/mL EthionamidecellWall

-0.159

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.021

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.118

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.482

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.522

BZA0.12 mg/mL BenzamidearomaticAmides

0.339

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.810

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.193

H2O24 mM hydrogen peroxideDNAdamaging

-0.699

Levo10 ug/mL LevofloxacinDNAdamaging

0.656

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.578

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.435

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.728

UVUV-irradiationDNAdamaging

0.332

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.168

Antimycin12.5-50 ug/mL Antimycin A?

-0.831

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.381

PA_110-50 ug/mL Antitubercular compound PA-1?

0.067

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.070

PA8240.2-2 ug/mL PA-824?

0.568

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.382

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.917

Verapamil50 uM Verapamil?

-1.154

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.755

methoxatin10-20 ug/mL Methoxatin?